Pelvic Abscess Formation Secondary to the Use of Commercial Hemostatic Topical Agent in an Immune Compromised Patient?
2017 ◽
Vol 3
(3)
◽
pp. 075-078
Keyword(s):
Keyword(s):
2015 ◽
Vol 2015
(apr23 1)
◽
pp. bcr2014208628-bcr2014208628
◽
2005 ◽
Vol 25
(2)
◽
pp. 197-198
◽
Keyword(s):
2014 ◽
Vol 80
(10)
◽
pp. 1078-1081
◽
2010 ◽
Vol 17
(6)
◽
pp. S150-S151
2009 ◽
Vol 16
(8)
◽
pp. 2204-2210
◽
2005 ◽
Vol 22
(4)
◽
pp. 173-175
◽
Keyword(s):